EMEIS 13.500 € (-2,67 %)
STIF 42.700 € (-2,18 %)
FDJ UNITED 25.820 € (0,00 %)
CEGEDIM 12.150 € (-0,82 %)
FERROVIAL 56.520 € (-1,87 %)
PULLUP ENTERTAIN 13.020 € (-1,96 %)
CVC CAPITAL 11.100 € (-2,63 %)
LOUIS HACHETTE 1.606 € (+1,61 %)
FERMENTALG 0.521 € (-2,98 %)
AUBAY 43.300 € (-1,93 %)
SANOFI 82.400 € (-0,57 %)
L'OREAL 353.975 € (-0,89 %)
AKZO NOBEL 48.960 € (-3,81 %)
LVMH 466.400 € (-1,00 %)
AIRBUS 163.840 € (-2,42 %)
VALBIOTIS 1.090 € (-0,18 %)
SCHNEIDER ELECTRIC 231.500 € (-3,52 %)
STELLANTIS NV 6.256 € (-1,06 %)
FORVIA 9.938 € (-2,33 %)
MAGNUM 12.490 € (+0,08 %)
ASML HOLDING 1 141.200 € (-3,91 %)
KPN KON 4.805 € (+0,75 %)
ACCOR 41.620 € (-0,72 %)
SARTORIUS STED BIO 165.450 € (-1,34 %)
REXEL 33.700 € (-2,18 %)
SHELL PLC 40.475 € (+2,40 %)
ASR NEDERLAND 60.380 € (-0,56 %)
COVIVIO 52.600 € (-1,50 %)
HEIJMANS KON 77.000 € (-4,35 %)
IPSEN 164.300 € (-0,48 %)
AXA 39.970 € (-0,50 %)
RELX 28.860 € (+0,42 %)
LATECOERE 0.020 € (-0,51 %)
AIR FRANCE -KLM 8.894 € (-4,59 %)
J.MARTINS,SGPS 20.960 € (0,00 %)
SAINT GOBAIN 70.520 € (-2,30 %)
AEGON 6.324 € (-1,09 %)
2CRSI 28.350 € (-3,41 %)
EUTELSAT COMMUNIC. 2.175 € (+1,16 %)
ELIS 24.880 € (-0,64 %)
WORLDLINE 0.273 € (+0,29 %)
ENGIE 28.430 € (+0,11 %)
ING GROEP N.V. 22.700 € (-2,30 %)
TOTALENERGIES 79.340 € (+2,29 %)
ABIONYX PHARMA 3.625 € (-1,49 %)
NX FILTRATION 2.490 € (-0,20 %)
UNILEVER 48.255 € (-0,09 %)
NANOBIOTIX 28.150 € (-2,76 %)
ABIVAX 97.300 € (-4,61 %)
DBT 0.058 € (+12,70 %)
AHOLD DEL 41.240 € (+0,10 %)
SBM OFFSHORE 34.860 € (+0,98 %)
EURAZEO 41.080 € (-1,49 %)
BNP PARIBAS ACT.A 83.210 € (-2,54 %)
ELIOR GROUP 2.528 € (-0,47 %)
ALTAREA 113.600 € (-1,22 %)
EUROFINS SCIENT. 65.640 € (+0,89 %)
SOITEC 50.780 € (-4,33 %)
BIOMERIEUX 92.800 € (+0,11 %)
PHARMING GROUP 1.435 € (-1,64 %) |
31/03/2026 06:30
Very strong order intake in the first quarter as conflict delayed revenue recognitionVAT Group AG / Key word(s): Development of Sales/Quarter Results “Ad hoc announcement pursuant to Art. 53 LR”
In the first quarter of 2026, demand in the semiconductor industry remained high. This led to very strong growth in order intake at VAT. However, due to conflict-related and temporary disruptions in its supply chain and adjustments to customer specifications, VAT now expects sales for the first quarter of 2026 of around CHF 215 million and below the guidance given at the beginning of March of CHF 240–260 million. The book-to-bill ratio is expected to be around 1.6x for the first quarter. The outbreak of the Middle East conflict in late February led to partial and temporary disruptions in VAT’s supply chain. Furthermore, late delivery of certain components and materials resulted in short-term adjustments to existing orders. In total, the negative impact on sales is estimated at approximately CHF 25 to 30 million in the first quarter. The situation has since been mitigated, and the reconfigured orders are expected to be delivered during the second quarter. VAT confirms positive outlook for 2026 and expects that order intake, revenue, EBITDA, EBITDA margin, net profit, and free cash flow for the full year 2026 will exceed the 2025 levels. More details will be provided during the trading update for the first quarter of 2026 on April 16, 2026. For further information please contact: Investor Relations Christopher Wickli +41 81 553 75 39 End of Inside Information
2300862 31-March-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière